
Lantern Pharma Advocates AI-Driven Approach to Address 'Broken' Biotech Model at Industry Summit
Lantern Pharma's CEO emphasized at the BioNTX iC3 Summit that AI platforms like RADR can streamline drug development, reduce costs, and accelerate timelines, positioning the company at the forefront of transforming the traditional biotech model.
Read full story



























